Prescription Orthopedic Drugs Global Market Report 2026
상품코드:1957689
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
정형외과 처방약 시장 규모는 최근 현저한 성장을 보이고 있습니다. 2025년 510억 6,000만 달러에서 2026년에는 540억 1,000만 달러에 이르고, CAGR 5.8%로 성장할 전망입니다. 지난 몇 년간 성장 요인으로는 높은 관절염 유병률, 정형외과 수술 증가, 비스테로이드성 항염증제(NSAID)의 광범위한 사용, 고령화에 따른 관절 질환 증가, 정형외과 의료시설의 확대 등을 꼽을 수 있습니다.
정형외과 처방약 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 675억 달러에 이르고, CAGR은 5.7%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 골관절염 환자 증가, 장기 통증 관리에 대한 수요 증가, 생물학적 정형외과 약물의 보급 확대, 스포츠 부상 발생률 증가, 정형외과 약품 처방 건수 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 통증 관리 요법에 대한 수요 증가, 항염증성 정형외과용 의약품의 사용 확대, 만성 관절 질환 치료에 대한 관심 증가, 정형외과 분야에서 DMARD(질병 변형 항류마티스제제) 사용 확대, 복합 통증 치료제의 도입 증가 등을 들 수 있습니다.
근골격계 질환의 유병률 증가는 향후 처방용 정형외과 의약품 시장 확대를 촉진할 것으로 예측됩니다. 근골격계 질환(MSDs)은 근육, 힘줄, 인대, 신경, 관절 등 인체의 근골격계에 영향을 미쳐 통증과 운동 기능 장애를 유발하는 손상이나 병태를 말합니다. 이러한 MSD 증가는 주로 고령화, 업무에 따른 반복적인 동작과 잘못된 자세, 건강에 해로운 식습관을 동반한 좌식 생활, 유전적 요인 등의 요인에 기인합니다. 처방이 필요한 정형외과용 의약품은 통증을 완화하고, 염증을 억제하고, 회복을 도와 궁극적으로 이동성과 삶의 질을 향상시키기 때문에 이러한 질환의 치료에 필수적입니다. 예를 들어, 2023년 3월 영국 건강격차개선청이 발표한 자료에 따르면, 16세 이상 장기 자가보고 근골격계 질환(MSK) 유병률은 2022년 17.6%에 달했습니다. 이러한 근골격계 질환 증가 추세는 처방용 정형외과 의약품 시장의 성장을 견인하고 있습니다.
처방용 정형외과 의약품 시장의 주요 업체들은 자사 제품의 적응증 확대를 우선순위에 두고 적용범위 확대를 꾀하고 있습니다. 예를 들어, 보다 광범위한 정형외과 및 연부조직 수술의 수술 후 통증 관리를 개선하기 위해 적응증 확대형 진통제 제제의 개발이 진행되고 있습니다. 적응증 확대형 진통제 제제는 당초 승인 범위를 넘어 더 많은 의료행위, 질환, 환자군으로 적용이 확대된 진통제를 말합니다. 예를 들어, 2023년 1월 미국 생명공학 기업 헤론 테라퓨틱스(Heron Therapeutics)가 ZYNRELEF(부피바카인과 멜록시캄의 복합제)의 적응증 확대를 FDA로부터 승인받았습니다. 이를 통해 족관절 수술을 포함한 연부조직 및 정형외과 수술에 사용할 수 있게 되었습니다. 이 서방형 제제는 최대 72시간 동안 지속적인 통증 완화를 제공하도록 특별히 설계되어 수술 후 오피오이드 사용을 줄이거 나 불필요하게 만드는 경우가 많습니다. 이번 적응증 확대로 족관절 수술을 포함한 더 많은 정형외과 및 연부조직 수술이 대상이 되어 임상 현장에서의 유용성이 더욱 높아졌습니다. 국소마취제와 항염증제의 특성을 결합한 이 혁신적인 이중 약물 접근법은 수술 후 통증 관리에 대한 종합적인 솔루션을 제공하여 환자의 치료 결과를 개선하는 데 기여합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Prescription orthopedic drugs are medications prescribed specifically to treat conditions impacting the musculoskeletal system, including bones, joints, muscles, and ligaments. They help relieve pain, reduce inflammation, and support healing in orthopedic injuries or disorders such as arthritis, fractures, and tendonitis.
The primary categories of prescription medications for orthopedic conditions include nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and additional types. Nonsteroidal anti-inflammatory drugs (NSAIDs) form a group of medicines that alleviate pain, swelling, and fever by blocking enzymes responsible for prostaglandin synthesis. Providers prescribe them for issues like osteoarthritis, rheumatoid arthritis, osteoporosis, and similar conditions. These medications reach patients via multiple outlets, such as hospital pharmacies, retail pharmacies, and online pharmacies.
Tariffs have increased the cost of imported APIs used in NSAIDs, corticosteroids, and biologics that are commonly prescribed for orthopedic conditions. These impacts are most evident in North America and Europe, where reliance on cross border sourcing has intensified pricing pressure. Rising tariff related expenses have influenced treatment affordability, reimbursement discussions, and procurement planning in orthopedic care. This has affected purchasing decisions across hospitals and specialty clinics. Positively, tariffs are encouraging domestic orthopedic drug production, expanded local manufacturing capacity, and stronger regional pharmaceutical supply chains over the long term.
The prescription orthopedic drugs market research report is one of a series of new reports from The Business Research Company that provides prescription orthopedic drugs market statistics, including prescription orthopedic drugs industry global market size, regional shares, competitors with a prescription orthopedic drugs market share, detailed prescription orthopedic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription orthopedic drugs industry. This prescription orthopedic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The prescription orthopedic drugs market size has grown strongly in recent years. It will grow from $51.06 billion in 2025 to $54.01 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to high prevalence of arthritis, increased orthopedic surgeries, widespread NSAID use, aging population joint disorders, expansion of orthopedic healthcare facilities.
The prescription orthopedic drugs market size is expected to see strong growth in the next few years. It will grow to $67.5 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising osteoarthritis cases, growing demand for long-term pain control, expansion of biologic orthopedic drugs, increased sports injury incidence, rising orthopedic drug prescriptions. Major trends in the forecast period include rising demand for pain management therapies, increased use of anti-inflammatory orthopedic drugs, growing focus on chronic joint disorder treatment, expansion of dmard usage in orthopedics, increased adoption of combination pain therapies.
The rising prevalence of musculoskeletal disorders is projected to fuel the expansion of the prescription orthopedic drugs market in the future. Musculoskeletal disorders (MSDs) refer to injuries and conditions impacting the human body's musculoskeletal system-which encompasses muscles, tendons, ligaments, nerves, and joints-leading to pain and impaired mobility. This uptick in MSDs stems mainly from factors like aging populations, work-related repetitive motions and poor postures, sedentary lifestyles coupled with unhealthy diets, and hereditary factors. Prescription orthopedic drugs are essential for treating these disorders, as they relieve pain, curb inflammation, and support recovery, ultimately boosting mobility and quality of life. For example, in March 2023, data from the UK's Office for Health Improvement & Disparities showed that the rate of long-term self-reported musculoskeletal (MSK) conditions among those aged 16 and older climbed to 17.6% in 2022. Thus, the growing incidence of musculoskeletal disorders is propelling the prescription orthopedic drugs market forward.
Major companies in the prescription orthopedic drugs market are prioritizing the expansion of indications for their drugs to widen their scope, such as developing extended-indication analgesic formulations to improve postoperative pain management for a wider array of orthopedic and soft-tissue procedures. An extended-indication analgesic formulation is a pain-relief medication whose approved clinical applications have been extended to include more medical procedures, conditions, or patient populations beyond its initial approval. For example, in January 2023, Heron Therapeutics Inc., a US-based biotechnology firm, secured FDA approval for the broadened use of ZYNRELEF (bupivacaine and meloxicam) in soft tissue and orthopedic procedures, including foot and ankle surgeries. This extended-release formulation is specially engineered to deliver sustained pain relief for up to 72 hours, often reducing or eliminating the need for post-surgical opioids. The expanded indication now encompasses more orthopedic and soft tissue procedures, including foot and ankle surgeries, increasing its utility in clinical practice. Its novel dual-drug approach combines local anesthetic and anti-inflammatory properties, offering a complete solution for postoperative pain control with better patient results.
In April 2024, ProMed Pharma LLC, a U.S.-based pharmaceutical firm, purchased SpineThera Inc. for an undisclosed sum. Through this acquisition, ProMed seeks to bolster its drug delivery expertise by tapping into SpineThera's proficiency in extended-release injectable treatments, especially for pain relief in musculoskeletal and orthopedic issues.
Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd.
North America was the largest region in the prescription orthopedic drugs market in 2025. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the prescription orthopedic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The prescription orthopedic drugs market consists of sales of products such as bisphosphonates, creams, gels, or patches, calcium and vitamin D supplements, and analgesics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Prescription Orthopedic Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses prescription orthopedic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prescription orthopedic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prescription orthopedic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Corticosteroids; Disease-Modifying Antirheumatic Drugs (DMARDs); Other Drug Types
2) By Application: Osteoarthritis; Rheumatoid Arthritis; Osteoporosis; Other Applications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.2 Increased Use Of Anti-Inflammatory Orthopedic Drugs
4.2.3 Growing Focus On Chronic Joint Disorder Treatment
4.2.4 Expansion Of Dmard Usage In Orthopedics
4.2.5 Increased Adoption Of Combination Pain Therapies
5. Prescription Orthopedic Drugs Market Analysis Of End Use Industries
5.1 Orthopedic Hospitals
5.2 Specialty Orthopedic Clinics
5.3 General Hospitals
5.4 Rehabilitation Centers
5.5 Homecare Patients
6. Prescription Orthopedic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Prescription Orthopedic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Prescription Orthopedic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Prescription Orthopedic Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Prescription Orthopedic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Prescription Orthopedic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Prescription Orthopedic Drugs Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.6. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Prescription Orthopedic Drugs Market
12.1. China Prescription Orthopedic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Prescription Orthopedic Drugs Market
13.1. India Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Prescription Orthopedic Drugs Market
14.1. Japan Prescription Orthopedic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Prescription Orthopedic Drugs Market
15.1. Australia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Prescription Orthopedic Drugs Market
16.1. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Prescription Orthopedic Drugs Market
17.1. South Korea Prescription Orthopedic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Prescription Orthopedic Drugs Market
19.1. South East Asia Prescription Orthopedic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Prescription Orthopedic Drugs Market
20.1. Western Europe Prescription Orthopedic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Prescription Orthopedic Drugs Market
21.1. UK Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Prescription Orthopedic Drugs Market
22.1. Germany Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Prescription Orthopedic Drugs Market
23.1. France Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Prescription Orthopedic Drugs Market
24.1. Italy Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Prescription Orthopedic Drugs Market
25.1. Spain Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Prescription Orthopedic Drugs Market
26.1. Eastern Europe Prescription Orthopedic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Prescription Orthopedic Drugs Market
27.1. Russia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Prescription Orthopedic Drugs Market
28.1. North America Prescription Orthopedic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Prescription Orthopedic Drugs Market
29.1. USA Prescription Orthopedic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Prescription Orthopedic Drugs Market
31.1. South America Prescription Orthopedic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Prescription Orthopedic Drugs Market
32.1. Brazil Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Prescription Orthopedic Drugs Market
33.1. Middle East Prescription Orthopedic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Prescription Orthopedic Drugs Market
34.1. Africa Prescription Orthopedic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Prescription Orthopedic Drugs Market Regulatory and Investment Landscape
36. Prescription Orthopedic Drugs Market Competitive Landscape And Company Profiles
